Skip to main content
MedicHelpLine
Join Free
Verified Professional Network190+ CountriesHIPAA-Aware Platform
Back to Drug Index
General MedicationsTOPICALGeneric

TRETINOIN

TRETINOIN

Standard Dose
0.04%
Max Dose
Refer to approved labeling
Primary Use
Review priority: STANDARD Marketing status: Discontinued
Summary

Approval overview TRETINOIN is listed in Drugs@FDA under application 202567 (ANDA).

Review priority: STANDARD Marketing status: Discontinued Active ingredient TRETINOIN Form and strength GEL;TOPICAL - 0.04% Sponsor RISING Submission history Latest submission status date: 2015-11-09 00:00:00.

Structured Monograph

Clinical summary

Approval overview TRETINOIN is listed in Drugs@FDA under application 202567 (ANDA). Review priority: STANDARD Marketing status: Discontinued Active ingredient TRETINOIN Form and strength GEL;TOPICAL - 0.04% Sponsor RISING Submission history Latest submission status date: 2015-11-09 00:00:00. Submission type: SUPPL.

Monitoring

  • • Marketing status: Discontinued
  • • Review priority: STANDARD

Interaction Notes

  • No interaction notes stored yet.